ArticleJournal of medicinal chemistry2022

Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia.

Nicole Bata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.